Your browser doesn't support javascript.
Gender-Based Violence Risk Mitigation by Non-GBV Specialists Prior to and during COVID-19: A Global Survey of Knowledge, Attitudes and Practices of Humanitarian Practitioners.
Sharma, Vandana; Gompers, Annika; Kelly, Jocelyn T D; Patrick, Erin; Heckman, Christine; Solomon, Arsema; Scott, Jennifer.
  • Sharma V; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
  • Gompers A; Harvard Humanitarian Initiative, Cambridge, MA 02138, USA.
  • Kelly JTD; Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
  • Patrick E; Harvard Humanitarian Initiative, Cambridge, MA 02138, USA.
  • Heckman C; Department of Emergency Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Solomon A; CARE, New York, NY 10017, USA.
  • Scott J; United Nations Children's Fund, New York, NY 10038, USA.
Int J Environ Res Public Health ; 18(24)2021 12 20.
Article in English | MEDLINE | ID: covidwho-1580714
ABSTRACT
Available evidence indicates that the COVID-19 pandemic and response measures may lead to increased risk of gender-based violence (GBV), including in humanitarian contexts. This study examined the knowledge, attitudes, and practices of humanitarian practitioners related to GBV risk mitigation approaches during COVID-19 in order to refine current guidance and inform future materials. A global, online cross-sectional survey of humanitarian practitioners was conducted between November 2020 and April 2021. We calculated descriptive statistics and used Chi-square or Fisher's exact tests to compare knowledge, attitudes, and practices among GBV specialists and non-specialists. Of 170 respondents, 58% were female and 44% were GBV specialists. Almost all (95%) of the respondents agreed or strongly agreed that they have a role to play in GBV risk mitigation. Compared to GBV specialists, a higher proportion of non-specialists reported little to no knowledge on GBV risk mitigation global guidance (38% vs. 7%, p < 0.001) and on how to respond to a disclosure of GBV (18% vs. 3%, p < 0.001). Respondents reported several barriers to integrating GBV risk mitigation into their work during COVID-19, including insufficient funding, capacity, knowledge, and guidance. Efforts to mainstream GBV risk mitigation actions should continue and intensify, leveraging the lessons and experiences generated thus far.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Gender-Based Violence / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Female / Humans Language: English Year: 2021 Document Type: Article Affiliation country: Ijerph182413387

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Gender-Based Violence / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Female / Humans Language: English Year: 2021 Document Type: Article Affiliation country: Ijerph182413387